About Kyorin Group

MIC-'09 Basic Strategy 3

Develop new businesses that build on the foundation of the pharmaceuticals business and contribute to future growth

To complement our drug discovery operations, which rely on a long-term, high-risk, high-return business model, and to stabilize growth, we are developing healthcare-related businesses in accordance with our philosophy. Specifically, we are expanding our generic drug business, which provides trusted products, and our healthcare business, which features the support of physicians.

Kyorin MIC-’09 Targeted Corporate Image

↑Page Top